Akonni Biosystems was recently awarded a $300,000 contract from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) to develop a low-cost, field-based device that can extract, purify, and stabilize DNA from sputum for molecular-based tuberculosis testing. The molecular diagnostics company will use the funds to further development to make…

Adding to the ever expanding list of molecular diagnostic uses for next-generation sequencing, investigators at John Hopkins University report that they were able to diagnose or rule out suspected brain infections using the advanced genetic sequencing technique on brain tissue samples. The findings from this study, which were recently published…

Generex Biotechnology has agreed to acquire for $15 million a 51% majority equity interest in Hema Diagnostic Systems (HDS), but could reap up to $50 million in royalties from gross sales of HDS tests, the companies said today. While saying it entered into a non-binding letter of intent for the…